期刊文献+

药源性心力衰竭的发生机理 被引量:1

下载PDF
导出
摘要 心力衰竭(heart failure,HF)是心室充盈或射血能力受损而引起的一组临床综合征。临床上大多数患者有左心室心肌功能受损及左室射血分数(LVEF)下降的症状。从病理生理学来看,能对心肌收缩、舒张功能,心脏前后负荷任一环节产生影响的因素都可以诱发或加重HF。近年来,关于HF诸方面的研究正越来越引起重视,然而,对于药物与HF的相关关系的研究却不多见。某些药物,如抗肿瘤药物、抗心律失常药物、钙通道阻滞剂、非甾体类抗炎药物等都可通过对心肌细胞直接毒性、产生负性肌力作用、增加心脏负荷不同机制诱发或加重HF。本文将探讨几类能诱发或加重HF的药物及其主要机理,旨在引起广大临床医师的足够重视。
作者 袁奕 张凤如
出处 《国际心血管病杂志》 2007年第4期251-254,共4页 International Journal of Cardiovascular Disease
  • 相关文献

参考文献15

  • 1[1]Slerdal L,Spigset O.Heart failure induced by non-cardiac drugs[J].Drug Safety,2006,29(7):567-586.
  • 2[2]Minotti G,Menna P,Salvatorelli E,et al.Anthracyclines:molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity[J].Pharmacol Rev,2004,56(2):185-229.
  • 3[3]Jensen BV,Skovsgaard T,Nielsen SL.Functional monitoring of anthracycline cardiotoxicity:a prospective,blinded,longterm observational study of outcome in 120 patients[J].Ann Oncol,2002,13 (5):699-709.
  • 4顾颖莉,朱汉威.环磷酰胺心脏毒性作用的研究进展[J].上海第二医科大学学报,2004,24(9):772-774. 被引量:14
  • 5[5]Pai VB,Nahata MC.Cardiotoxicity of chemotherapeutic agents:incidence,treatment,and prevention[J].Drug Saf,2000,22(4):263-302.
  • 6[6]Yeh ET,Tong AT,Lenihan DJ,et al.Cardiovascular complications of cancer therapy:diagnosis,Pathogenesis,and management[J].Circulation,2004,109(25):3122-3131.
  • 7[7]Yeh ET.Cardiotoxicity induced by chemotherapy and antibody therapy[J].Annu Rev Med,2006,57:485-498.
  • 8[8]Seidman A,Hudis C,Pierri MK,et al.Cardiac dysfunction in the trastuzumab clinical trials experience[J].J Clin Oncol,2002,20(5):1215-1221.
  • 9[9]Feenstra J,Heerdink ER,Grobbe DE,et al.Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure:the Rotterdam Study[J].Arch Intern Med,2002,162(3):265-270.
  • 10[10]Mamdani M,Juurlind DN,Lee DS,et al.Cyclo-oxygenase2inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients:a population-based cohort study[J].Lancet,2004,363:175-176.

二级参考文献13

  • 1Santos GW, Sensenbrener L, Burke PJ, et al. Marrow transplantation in man following cyclophosphamide [ J ]. Transplant Proc,1971, 2:400-404.
  • 2Kumar S, Gupta RK, Bhake AS, et al. Cardiotoxic effects of high doses of cyclophosphamide in albino rats[ J ]. Arch Int Pharmacodyn Ther, 1992, 319:58-65.
  • 3Hopkins HA, Betsill WL, Hobson Jr AS, et al. Cyclophosphamideinduced cardiomyopathy in the rat [ J]. Cancer Treatment Reports,1982, 66(7): 1 521 -1 527.
  • 4Fraiser LH, Kanekal S, Kehrer JP. Cyclophosphamide toxicity:characterising and avoiding the problem[ J]. Drugs, 1991,42 (5):781 - 795.
  • 5Colvin M, Hilton J. Pharmacology of cyclophosphamide and metabolites[J]. Cancer Treatment Reports, 1981, 65 ( Suppl. 3 ): S89- S95.
  • 6Kachel DL, Martin WJ 2nd. Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury[ J]. J Pharmacol Exp Ther, 1994, 268(1): 42-46.
  • 7Mills BA, Roberts RW. Cyclophosphamide-induced cardiomyopathy: a report of two cases and review of the English literature [ J ].Cancer, 1979,43:2 223 -2 226.
  • 8Steinherz LJ, Steinherz PJ, Mangiacasale D, et al. Cardiac changes with cyclophosphamide[ J]. Med Pediatr Oncol, 1981, 9: 417-422.
  • 9Braverman AC, Antin JH, Plappert MT, et al. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens [ J ]. Journal of Clinical Oncology,1991, 9(7): 1 215-1 223.
  • 10Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention [ J ]. Drug Saf, 2000, 22 (4):263 - 302.

共引文献13

同被引文献16

引证文献1

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部